213 related articles for article (PubMed ID: 17982138)
21. Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.
Hayashi Y; Nemoto-Sasaki Y; Tanikawa T; Oka S; Tsuchiya K; Zama K; Mitsutake S; Sugiura T; Yamashita A
J Biol Chem; 2014 Oct; 289(44):30842-30856. PubMed ID: 25231990
[TBL] [Abstract][Full Text] [Related]
22. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
[TBL] [Abstract][Full Text] [Related]
23. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
[TBL] [Abstract][Full Text] [Related]
24. Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane.
Deevska G; Dotson PP; Mitov M; Butterfield DA; Nikolova-Karakashian M
Cells; 2021 May; 10(6):. PubMed ID: 34064003
[TBL] [Abstract][Full Text] [Related]
25. A sensitive cell-based method to screen for selective inhibitors of SMS1 or SMS2 using HPLC and a fluorescent substrate.
Zama K; Mitsutake S; Watanabe K; Okazaki T; Igarashi Y
Chem Phys Lipids; 2012 Oct; 165(7):760-8. PubMed ID: 23063490
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
[TBL] [Abstract][Full Text] [Related]
27. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.
Wang X; Dong J; Zhao Y; Li Y; Wu M
Lipids Health Dis; 2011 Jan; 10():7. PubMed ID: 21235823
[TBL] [Abstract][Full Text] [Related]
29. Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity.
Chiang YP; Li Z; Chen Y; Cao Y; Jiang XC
J Biol Chem; 2021 Dec; 297(6):101398. PubMed ID: 34774525
[TBL] [Abstract][Full Text] [Related]
30. Switching head group selectivity in mammalian sphingolipid biosynthesis by active-site engineering of sphingomyelin synthases.
Kol M; Panatala R; Nordmann M; Swart L; van Suijlekom L; Cabukusta B; Hilderink A; Grabietz T; Mina JG; Somerharju P; Korneev S; Tafesse FG; Holthuis JC
J Lipid Res; 2016 Jul; 57(7):1273-85. PubMed ID: 27165857
[TBL] [Abstract][Full Text] [Related]
31. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
[TBL] [Abstract][Full Text] [Related]
32. Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury.
Gowda S; Yeang C; Wadgaonkar S; Anjum F; Grinkina N; Cutaia M; Jiang XC; Wadgaonkar R
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L430-40. PubMed ID: 21191108
[TBL] [Abstract][Full Text] [Related]
33. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
[TBL] [Abstract][Full Text] [Related]
34. Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.
Deevska GM; Dotson PP; Karakashian AA; Isaac G; Wrona M; Kelly SB; Merrill AH; Nikolova-Karakashian MN
J Biol Chem; 2017 Mar; 292(12):5110-5122. PubMed ID: 28087695
[TBL] [Abstract][Full Text] [Related]
35. Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus.
Taniguchi M; Tasaki T; Ninomiya H; Ueda Y; Kuremoto KI; Mitsutake S; Igarashi Y; Okazaki T; Takegami T
Sci Rep; 2016 Nov; 6():37829. PubMed ID: 27892528
[TBL] [Abstract][Full Text] [Related]
36. Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells.
Yamaoka S; Miyaji M; Kitano T; Umehara H; Okazaki T
J Biol Chem; 2004 Apr; 279(18):18688-93. PubMed ID: 14976195
[TBL] [Abstract][Full Text] [Related]
37. Regulation of membrane KCNQ1/KCNE1 channel density by sphingomyelin synthase 1.
Wu M; Takemoto M; Taniguchi M; Takumi T; Okazaki T; Song WJ
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C15-23. PubMed ID: 27194473
[TBL] [Abstract][Full Text] [Related]
38. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
[TBL] [Abstract][Full Text] [Related]
39. Sphingomyelin in microdomains of the plasma membrane regulates amino acid-stimulated mTOR signal activation.
Zama K; Mitsutake S; Okazaki T; Igarashi Y
Cell Biol Int; 2018 Jul; 42(7):823-831. PubMed ID: 29369436
[TBL] [Abstract][Full Text] [Related]
40. Sphingomyelin synthase 2 is palmitoylated at the COOH-terminal tail, which is involved in its localization in plasma membranes.
Tani M; Kuge O
Biochem Biophys Res Commun; 2009 Apr; 381(3):328-32. PubMed ID: 19233134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
